Chemical Structure : CHIR-99021
CAS No.: 252917-06-9
货号: PC-42428Not For Human Use, Lab Use Only.
Laduviglusib (CHIR-99021, CT99021) is a potent, specific GSK-3 inhibitor with IC50 of 5 nM and 10 nM for GSK3β and GSK3α, respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥880 | In stock | |
10 mg | ¥1280 | In stock | |
25 mg | ¥2180 | In stock | |
50 mg | ¥3780 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Laduviglusib (CHIR-99021, CT99021) is a potent, specific GSK-3 inhibitor with IC50 of 5 nM and 10 nM for GSK3β and GSK3α, respectively.
Laduviglusib (CHIR-99021, CT99021) mimics Wnt signaling in preadipocytes, stabilizes free cytosolic beta-catenin and inhibits adipogenesis by blocking induction of C/EBPα and PPARγ.
Laduviglusib (CHIR-99021, CT99021) potentiates insulin activation of glucose transport and utilization in vitro and in vivo.
Laduviglusib (CHIR-99021, CT99021) is also widely used for stem cell differentiation and naive stem cell generation.
分子量 | 465.3379 | |
分子式 | C22H18Cl2N8 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: ≥ 5.1 mg/mL |
|
Chemical Name/SMILES |
3-Pyridinecarbonitrile, 6-[[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]- |
1. Ying QL, et al. Nature. 2008 May 22;453(7194):519-23.
2. Ring DB, et al. Diabetes. 2003 Mar;52(3):588-95.
3. Bennett CN, et al. J Biol Chem. 2002 Aug 23;277(34):30998-1004.
4. Li W, et al. Stem Cells. 2009 Dec;27(12):2992-3000.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright